Tempest Therapeutics Inc (TPST)

Mar 25, 2026

Angel Matthew, CEO and president, buys Tempest Therapeutics shares for $500k - Investing.com Australia

Mar 25, 2026

Mar 25, 2026

Tempest Therapeutics Insider Bought Shares Worth $500,001, According to a Recent SEC Filing - Moomoo

Mar 25, 2026

Mar 25, 2026

Matthew Angel’s 37.4% Tempest (NASDAQ: TPST) stake tied to asset deal, private placement - Stock Titan

Mar 25, 2026

Mar 25, 2026

Factor Bioscience tied to Tempest (NASDAQ: TPST) CEO buys 231,482 shares - Stock Titan

Mar 25, 2026

Mar 25, 2026

Downgrade Watch: Can Tempest Therapeutics Inc reach all time highs this yearRate Hike & Daily Profit Focused Screening - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

Aug Macro: Will Tempest Therapeutics Inc stock recover after earningsMarket Trend Review & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

TPST Q4'25 Earnings: revenue estimate is 0 USD - TradingView

Mar 25, 2026

Mar 25, 2026

2.26 out - Moomoo

Mar 25, 2026

Mar 25, 2026

Tempest Therapeutics (TPST) Projected to Post Quarterly Earnings on Wednesday - Defense World

Mar 25, 2026

Mar 24, 2026

Tempest Therapeutics raises $2 million in private placement By Investing.com - Investing.com Canada

Mar 24, 2026

Mar 23, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics Announces $2 Million Private Placement and Securities Purchase Agreement with Institutional and Strategic Investors - Minichart

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics Announces Private Placement Financing Agreement - TipRanks

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics Raises $2.0 Million in Private Placement With Warrants Priced at $2.16 - TradingView

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics (Nasdaq: TPST) details $2.0 million private placement deal - Stock Titan

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics Announces Up To $6 Million Private Placement - Bitget

Mar 23, 2026

Mar 23, 2026

Cancer drug developer Tempest lines up up to $6M in funding - Stock Titan

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics Inc expected to post a loss of 62 cents a shareEarnings Preview - TradingView

Mar 23, 2026

Mar 22, 2026

Technical Analysis: Is Tempest Therapeutics Inc exposed to political risk2026 Growth vs Value & Capital Protection Trade Alerts - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

Aug Final Week: Is Tempest Therapeutics Inc stock a value trap2026 Retail & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Is Tempest Therapeutics Inc stock a value trapWeekly Profit Analysis & Long Hold Capital Preservation Plans - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Whats the MACD signal for Tempest Therapeutics IncMarket Volume Summary & Low Drawdown Momentum Ideas - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Tempest Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | | US87978U2078 - marketscreener.com

Mar 20, 2026

Mar 19, 2026

Tempest Therapeutics, Inc. announced that it expects to receive $2 million in funding - marketscreener.com

Mar 19, 2026

Mar 16, 2026

Aug Fed Impact: Is Tempest Therapeutics Inc gaining market shareCEO Change & Safe Entry Point Identification - baoquankhu1.vn

Mar 16, 2026

Mar 16, 2026

Exit Recap: Is Tempest Therapeutics Incs growth already priced in2026 Reactions & Real-Time Chart Pattern Alerts - baoquankhu1.vn

Mar 16, 2026

Mar 11, 2026

Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026 - Bitget

Mar 11, 2026

Mar 11, 2026

Tempest Therapeutics Inc. (referred to as Tempest) recently disclosed a strategic collaboration regarding its core candidate drug Tpst-2003. - Bitget

Mar 11, 2026

Mar 08, 2026

Growth Review: Is Tempest Therapeutics Incs growth already priced in2026 Pullback Review & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Mar 08, 2026

Mar 06, 2026

Growth Value: Whats the outlook for Tempest Therapeutics Incs sectorWeekly Stock Summary & Verified Short-Term Trading Plans - baoquankhu1.vn

Mar 06, 2026

Mar 04, 2026

Earnings Recap: Is Tempest Therapeutics Inc stock a value trap2025 EndofYear Setup & Smart Swing Trading Techniques - baoquankhu1.vn

Mar 04, 2026

Mar 04, 2026

IPO Launch: Is AMBIWS a strong candidate for buy and hold2025 Analyst Calls & Daily Technical Stock Forecast Reports - baoquankhu1.vn

Mar 04, 2026

Mar 04, 2026

TPST Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Feb 27, 2026

Tempest Therapeutics, Inc. (TPST) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Feb 27, 2026

Feb 26, 2026

Tempest Therapeutics, Inc.Common Stock (NQ: TPST - FinancialContent

Feb 26, 2026

Feb 26, 2026

Tempest Therapeutics reports complete response in myeloma trial By Investing.com - Investing.com Australia

Feb 26, 2026

Feb 25, 2026

EX-99.1 - SEC.gov

Feb 25, 2026

Feb 25, 2026

Tempest Therapeutics reports complete response in myeloma trial - Investing.com

Feb 25, 2026

Feb 25, 2026

Tempest Therapeutics Advances TPST-2003 CAR-T with Strong Data - TipRanks

Feb 25, 2026

Feb 25, 2026

Tempest reports 100% ORR in evaluable TPST-2003 patients, plans U.S. registrational study in 2026 - TradingView

Feb 25, 2026

Feb 25, 2026

Tempest Therapeutics (TPST) reveals 100% response in TPST-2003 multiple myeloma study - Stock Titan

Feb 25, 2026

Feb 25, 2026

Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026 - Bitget

Feb 25, 2026

Feb 25, 2026

Tempest Announces Interim Results from Ongoing REDEEM-1 - GlobeNewswire

Feb 25, 2026

Feb 20, 2026

Why Tempest Therapeutics Inc. stock could outperform in 2025Weekly Profit Recap & Free Community Supported Trade Ideas - mfd.ru

Feb 20, 2026

Feb 17, 2026

How Tempest Therapeutics Inc. stock reacts to global recession fearsMarket Sentiment Report & AI Enhanced Execution Alerts - mfd.ru

Feb 17, 2026

Feb 16, 2026

Is Tempest Therapeutics Inc.’s growth already priced inBuy Signal & Daily Oversold Bounce Ideas - mfd.ru

Feb 16, 2026

Feb 15, 2026

What catalysts could drive Tempest Therapeutics Inc. stock higher2025 Earnings Impact & Free High Return Stock Watch Alerts - mfd.ru

Feb 15, 2026

Feb 14, 2026

Will Tempest Therapeutics Inc. stock recover after earningsM&A Rumor & Advanced Swing Trade Entry Plans - mfd.ru

Feb 14, 2026

Feb 14, 2026

TPST Should I Buy - Intellectia AI

Feb 14, 2026

Feb 12, 2026

How cyclical is Tempest Therapeutics Inc.’s revenue streamEarnings Performance Report & Smart Swing Trading Techniques - mfd.ru

Feb 12, 2026

Feb 12, 2026

Tempest Therapeutics Highlights Partner-Funded CAR-T Oncology Pipeline - The Globe and Mail

Feb 12, 2026

Feb 11, 2026

Tempest lays out strategic plan to advance recently acquired dual-targeting CAR-T assets - marketscreener.com

Feb 11, 2026

Feb 11, 2026

Tempest Therapeutics outlines plans for acquired CAR T assets - bioworld.com

Feb 11, 2026

Feb 11, 2026

Tempest Therapeutics, Inc. Updates on Oncology Pipeline and Clinical Progress - TradingView

Feb 11, 2026

Feb 11, 2026

Partner-funded China trials anchor Tempest’s new CAR-T push - Stock Titan

Feb 11, 2026

Feb 07, 2026

Key facts: Tempest Therapeutics announces management changes; issues warrants - TradingView

Feb 07, 2026

Feb 06, 2026

Tempest Therapeutics Signs Warrant Agreement With Computershare - TradingView

Feb 06, 2026

Feb 06, 2026

Tempest Therapeutics (NASDAQ: TPST) closes CAR T acquisition and names new CEO - Stock Titan

Feb 06, 2026

Feb 05, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Feb 05, 2026